Detalhe da pesquisa
1.
Belinostat resolves skin barrier defects in atopic dermatitis by targeting the dysregulated miR-335:SOX6 axis.
J Allergy Clin Immunol
; 146(3): 606-620.e12, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32088305
2.
IL-17-Mediated Downregulation of miR-101 Facilitates the Expression of EZH2 to Promote Epidermal Hyperplasia in Psoriasis.
J Invest Dermatol
; 144(2): 403-407.e7, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574185